143 related articles for article (PubMed ID: 7453834)
1. Antagonism of the renal vasodilator activity of dopamine by metoclopramide.
Hahn RA; Wardell JR
Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):177-82. PubMed ID: 7453834
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
Hahn RA; Wardell JR; Sarau HM; Ridley PT
J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the vasomotor effects of dopamine on the renal and iliac arterial beds of the anesthetized rat].
Schmidt M; Giesen-Crouse E; Fontaine C; Imbs JL
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):820-3. PubMed ID: 3026271
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
Woodman OL; Rechtman MP; Lang WJ
Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
[TBL] [Abstract][Full Text] [Related]
6. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists.
Nishiyama S; Yoshikawa M; Yamaguchi I
J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621
[TBL] [Abstract][Full Text] [Related]
7. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
Kohli JD; Goldberg LI; Volkman PH; Cannon JG
J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vascular dopamine receptors in the gastric circulation of the rabbit.
Reinsberg J; Kullmann R
J Cardiovasc Pharmacol; 1986; 8(5):1067-73. PubMed ID: 2429081
[TBL] [Abstract][Full Text] [Related]
9. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
Hom GJ; Jandhyala BS
J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
[TBL] [Abstract][Full Text] [Related]
10. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
Lass NA; Glock D; Goldberg LI
Circulation; 1988 Nov; 78(5 Pt 1):1310-5. PubMed ID: 2902941
[TBL] [Abstract][Full Text] [Related]
12. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390.
Goldberg LI; Glock D; Kohli JD; Barnett A
Hypertension; 1984; 6(2 Pt 2):I25-30. PubMed ID: 6144634
[TBL] [Abstract][Full Text] [Related]
13. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
Kohli JD; Glock D; Goldberg LI
J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
[TBL] [Abstract][Full Text] [Related]
14. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
[TBL] [Abstract][Full Text] [Related]
15. Effect of metoclopramide on renal vascular resistance index and renal function in patients receiving a low-dose infusion of dopamine.
Munn J; Tooley M; Bolsin S; Hronek I; Lowson S; Willcox J
Br J Anaesth; 1993 Sep; 71(3):379-82. PubMed ID: 8398519
[TBL] [Abstract][Full Text] [Related]
16. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
[TBL] [Abstract][Full Text] [Related]
17. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
Hahn RA; Wardell JR
J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
[No Abstract] [Full Text] [Related]
18. Selective DA2 versus DA1 antagonist activity of domperidone in the periphery.
Kohli JD; Glock D; Goldberg LI
Eur J Pharmacol; 1983 Apr; 89(1-2):137-41. PubMed ID: 6861882
[TBL] [Abstract][Full Text] [Related]
19. Human vasodilator responses to a dopamine agonist: possible mechanisms.
Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
[TBL] [Abstract][Full Text] [Related]
20. Renal vasodilation by a prostaglandin analog during dopaminergic and alpha-adrenergic blockade.
Seymour AA; Blaine EH
Prostaglandins Leukot Med; 1983 Mar; 10(3):349-60. PubMed ID: 6133286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
